Cutting Gel Reviews
Although NutraSport
claims in its ads and product insert that "published clinical
trials prove Cutting Gel's power," a search of scientific
databases turned up no evidence of such studies. While aminophylline
was once used for the treatment of congestive heart failure (and
studied as an individual orally administered ingredient), there
are no studies showing that it (or lecithin) can be absorbed through
the skin.
Also, the Cutting Gel package says that
it is licensed under U.S. Patents 4,525,359 and 4,588,724. However,
a review of these patents, which are virtually identical in wording,
shows only the weakest of links to the actual product. The patents
discuss a method of selectively reducing body fat by use of an
alpha-2 adrenergic inhibitor such as yohimbine or a beta-adrenergic
stimulator like forskolin or isoproterenol. These nutrients are
injected, implanted or applied topically in the area where body-fat
reduction is desired.
Unfortunately, nowhere in these patents are the ingredients in
Cutting Gel listed. The closest the product comes is aminophylline,
which is chemically related to theophylline, a beta-adrenergic
stimulator. Moreover, while the patent says that topical application
is a permissible way to administer these chemicals, the study
mentioned in the patent used an injection of isoproterenol to
spot reduce. It is a major stretch to say that rubbing a different
chemical on your skin will produce the same results.
By the way, if you want to read about this or any other patent,
visit the U.S. Patent and Trademark Office Web site at www.uspto.gov.
Hit the Patents icon, click on Search Patents (the first line
of the Services list) and then on Patent Number Search. Enter
the patent number and the full text will appear for your review.
For more information
on Cutting Gel, please click on the following links:
|
